Market Niche CapPlus Technologies uniquely offers equipment to manufacture all three solid-dose forms (tablets, capsules, softgels) and can supply single machines or complete production lines, presenting a compelling value proposition for pharmaceutical manufacturers seeking versatile, integrated packaging and production solutions.

Growth Potential With annual revenue in the 10-25 million range and a niche focus on diverse solid-dose machinery, there is an opportunity to upsell expanded line integrations, after-market services, and modernization projects to mid-sized pharmaceutical producers looking to scale operations.

Strategic Partners Target companies operating multi-format dosage portfolios or evolving from single-form production to integrated lines. Emphasize CapPlus’s ability to consolidate equipment vendors and reduce procurement complexity for faster deployment.

Geographic Focus Headquartered in Phoenix, AZ, capabilites can be highlighted for U.S.-based manufacturers seeking local or nearshore equipment supply, commissioning, and service support, reducing downtime and improving service responsiveness.

Competitive Position Position CapPlus as a specialized supplier with a unique breadth of solid-dose machinery offerings in the U.S., complementing or differentiating from peers by showcasing end-to-end line capabilities and flexibility across capsule, tablet, and softgel production.